ALGN

Align Technology, Inc. NASDAQ

Healthcare ·Medical - Devices ·US · aligntech.com

$178.91

After hrs $171.88 +0.00%

Mkt Cap $13.0B

52w Low $122.00 65.9% of range 52w High $208.31

50d MA $179.69 200d MA $158.67

P/E (TTM) 31.6x

EV/EBITDA 13.5x

P/B 3.2x

Debt/Equity 0.0x

ROE 10.1%

P/FCF 23.1x

RSI (14) —

ATR (14) —

Beta 1.81

50d MA $179.69

200d MA $158.67

Avg Volume 1.3M

About

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign… Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 29, 2026	AMC	2.26	2.58	+14.2%	178.40	-0.8%	-1.3%	+0.3%	—	—	—	—	—
Feb 4, 2026	AMC	2.99	3.29	+10.0%	161.30	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%	+7.9%	—
Oct 29, 2025	AMC	2.40	2.61	+8.8%	131.91	+10.1%	+4.9%	+4.5%	+5.0%	+2.9%	+4.0%	+11.6%	—
Jul 30, 2025	AMC	2.57	2.49	-3.1%	203.57	-30.0%	-36.6%	-32.9%	-32.3%	-31.4%	-32.8%	-30.3%	—
Apr 30, 2025	AMC	1.99	2.13	+7.0%	173.30	+9.6%	+2.0%	+3.8%	+2.5%	-0.1%	-0.6%	+4.4%	—
Feb 5, 2025	AMC	2.43	2.44	+0.4%	216.36	+5.1%	+0.9%	-2.7%	-2.0%	-2.7%	-5.1%	-19.7%	—
Oct 23, 2024	AMC	2.31	2.35	+1.7%	207.66	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%	+8.8%	—
Jul 24, 2024	AMC	2.34	2.41	+3.0%	244.80	-6.8%	-7.7%	-9.9%	-8.5%	-5.6%	-5.3%	-4.4%	—
Apr 24, 2024	AMC	1.97	2.14	+8.6%	313.78	+3.6%	-1.0%	-1.5%	-2.9%	-10.0%	-9.3%	-18.5%	—
Jan 31, 2024	AMC	2.18	2.42	+11.0%	267.32	+13.3%	+2.3%	+2.5%	+3.1%	+7.9%	+6.5%	+12.2%	—
Oct 25, 2023	AMC	2.26	2.14	-5.3%	253.69	-22.4%	-24.9%	-24.7%	-26.4%	-27.2%	-27.8%	-13.5%	—
Jul 26, 2023	AMC	2.02	2.22	+9.9%	339.85	+18.8%	+13.4%	+12.4%	+11.2%	+10.8%	+8.1%	+4.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 30	Evercore ISI	Maintains	Outperform → Outperform	—	$178.40	$177.00	-0.8%	-1.3%	+0.3%	—	—	—
Apr 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$190.67	$190.96	+0.2%	-0.6%	-3.1%	-7.0%	-6.4%	-7.7%
Apr 21	Piper Sandler	Maintains	Overweight → Overweight	—	$191.66	$193.40	+0.9%	+1.8%	+2.3%	-0.5%	-1.1%	-3.6%
Mar 17	Barclays	Upgrade	Equal Weight → Overweight	—	$169.45	$174.19	+2.8%	+3.9%	+1.7%	+4.0%	+2.2%	+6.7%
Feb 26	Barclays	Maintains	Equal Weight → Equal Weight	—	$188.05	$188.53	+0.3%	+0.6%	+1.1%	+0.5%	-2.9%	-3.1%
Feb 9	HSBC	Upgrade	Hold → Buy	—	$187.60	$188.00	+0.2%	+2.6%	+4.6%	+5.3%	-2.0%	-0.4%
Feb 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Feb 5	Wells Fargo	Maintains	Overweight → Overweight	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Feb 5	Piper Sandler	Maintains	Overweight → Overweight	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Feb 5	UBS	Maintains	Neutral → Neutral	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Feb 5	Stifel	Maintains	Buy → Buy	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Feb 5	Evercore ISI	Maintains	Outperform → Outperform	—	$161.30	$176.06	+9.2%	+8.9%	+16.3%	+19.3%	+21.7%	+22.4%
Jan 20	Mizuho	Maintains	Outperform → Outperform	—	$171.49	$167.28	-2.5%	-3.5%	-0.9%	-1.5%	-1.6%	-2.2%
Oct 30	Wells Fargo	Maintains	Overweight → Overweight	—	$131.91	$145.22	+10.1%	+4.9%	+4.5%	+5.0%	+2.9%	+4.0%
Oct 30	Piper Sandler	Maintains	Overweight → Overweight	—	$131.91	$145.22	+10.1%	+4.9%	+4.5%	+5.0%	+2.9%	+4.0%
Oct 30	Evercore ISI	Maintains	Outperform → Outperform	—	$131.91	$145.22	+10.1%	+4.9%	+4.5%	+5.0%	+2.9%	+4.0%
Oct 30	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$131.91	$145.22	+10.1%	+4.9%	+4.5%	+5.0%	+2.9%	+4.0%
Oct 21	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$134.93	$133.62	-1.0%	+1.0%	+0.5%	+0.8%	+0.2%	+0.5%
Oct 16	UBS	Maintains	Neutral → Neutral	—	$128.43	$129.14	+0.6%	+1.1%	+1.6%	+5.1%	+6.1%	+5.6%
Oct 13	Mizuho	Maintains	Outperform → Outperform	—	$125.79	$127.25	+1.2%	+3.0%	+3.2%	+2.1%	+3.2%	+3.7%
Oct 10	Jefferies	Downgrade	Buy → Hold	—	$131.87	$128.70	-2.4%	-4.6%	-1.8%	-1.6%	-2.6%	-1.5%
Oct 8	Evercore ISI	Maintains	Outperform → Outperform	—	$130.47	$130.56	+0.1%	+2.0%	+1.1%	-3.6%	-0.7%	-0.5%
Jul 31	Stifel	Maintains	Buy → Buy	—	$203.57	$142.50	-30.0%	-36.6%	-32.9%	-32.3%	-31.4%	-32.8%
Jul 31	Piper Sandler	Maintains	Overweight → Overweight	—	$203.57	$142.50	-30.0%	-36.6%	-32.9%	-32.3%	-31.4%	-32.8%
Jul 31	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$203.57	$142.50	-30.0%	-36.6%	-32.9%	-32.3%	-31.4%	-32.8%
Jul 31	Wells Fargo	Maintains	Overweight → Overweight	—	$203.57	$142.50	-30.0%	-36.6%	-32.9%	-32.3%	-31.4%	-32.8%
Jul 9	Evercore ISI	Maintains	Outperform → Outperform	—	$195.47	$197.05	+0.8%	+2.6%	+4.6%	+3.5%	+2.0%	-1.4%
May 1	Needham	Maintains	Hold → Hold	—	$173.30	$190.00	+9.6%	+2.0%	+3.8%	+2.5%	-0.1%	-0.6%
May 1	Piper Sandler	Maintains	Overweight → Overweight	—	$173.30	$190.00	+9.6%	+2.0%	+3.8%	+2.5%	-0.1%	-0.6%
May 1	Evercore ISI	Maintains	Outperform → Outperform	—	$173.30	$190.00	+9.6%	+2.0%	+3.8%	+2.5%	-0.1%	-0.6%
May 1	Wells Fargo	Maintains	Overweight → Overweight	—	$173.30	$190.00	+9.6%	+2.0%	+3.8%	+2.5%	-0.1%	-0.6%
Apr 29	Mizuho	Maintains	Outperform → Outperform	—	$181.09	$181.56	+0.3%	-1.8%	-4.3%	-2.4%	-0.7%	-1.9%
Apr 25	HSBC	Downgrade	Buy → Hold	—	$184.27	$181.51	-1.5%	-0.5%	-1.7%	-3.5%	-6.0%	-4.1%
Apr 24	UBS	Maintains	Neutral → Neutral	—	$177.23	$178.16	+0.5%	+4.0%	+3.5%	+2.2%	+0.3%	-2.2%
Apr 15	Morgan Stanley	Maintains	Overweight → Overweight	—	$165.62	$165.89	+0.2%	-0.9%	+0.9%	+3.5%	+4.0%	+5.0%
Mar 25	Mizuho	Maintains	Outperform → Outperform	—	$170.37	$170.92	+0.3%	-0.2%	-2.3%	-3.6%	-6.6%	-6.8%
Mar 18	Piper Sandler	Maintains	Overweight → Overweight	—	$169.59	$168.00	-0.9%	-3.0%	-2.0%	-0.5%	-0.6%	+0.5%
Feb 6	Needham	Maintains	Hold → Hold	—	$216.36	$227.46	+5.1%	+0.9%	-2.7%	-2.0%	-2.7%	-5.1%
Feb 6	Evercore ISI	Maintains	Outperform → Outperform	—	$216.36	$227.46	+5.1%	+0.9%	-2.7%	-2.0%	-2.7%	-5.1%
Feb 6	Piper Sandler	Maintains	Overweight → Overweight	—	$216.36	$227.46	+5.1%	+0.9%	-2.7%	-2.0%	-2.7%	-5.1%
Feb 6	Morgan Stanley	Maintains	Overweight → Overweight	—	$216.36	$227.46	+5.1%	+0.9%	-2.7%	-2.0%	-2.7%	-5.1%
Jan 23	Jefferies	Maintains	Buy → Buy	—	$232.14	$231.63	-0.2%	+1.2%	+0.5%	-1.0%	-2.6%	-3.3%
Jan 6	Leerink Partners	Upgrade	Market Perform → Outperform	—	$208.26	$215.31	+3.4%	+5.1%	+4.5%	+3.4%	+1.9%	+2.6%
Dec 13	BofA Securities	Maintains	Underperform → Underperform	—	$235.72	$235.19	-0.2%	-0.1%	-2.4%	-2.9%	-9.8%	-9.4%
Oct 24	Baird	Maintains	Outperform → Outperform	—	$207.66	$214.48	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%
Oct 24	Piper Sandler	Maintains	Overweight → Overweight	—	$207.66	$214.48	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%
Oct 24	Stifel	Maintains	Buy → Buy	—	$207.66	$214.48	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%
Oct 24	Morgan Stanley	Maintains	Overweight → Overweight	—	$207.66	$214.48	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%
Oct 24	Evercore ISI	Maintains	Outperform → Outperform	—	$207.66	$214.48	+3.3%	+4.2%	+5.6%	+3.9%	+2.5%	+1.5%
Oct 17	Piper Sandler	Maintains	Overweight → Overweight	—	$216.05	$217.97	+0.9%	-0.0%	+1.7%	+0.2%	-2.4%	-3.9%

Recent Filings

8-K · 5.03 ! Medium

Align Technology Inc -- 8-K 5.03: Amendment to Articles / Bylaws

Align Technology (ALGN) changed its fiscal year-end, which may affect the timing of future financial reporting and earnings announcements for investors tracking the company's performance cycles.

Feb 26

8-K

Align Technology Inc -- 8-K Filing

Align Technology delivered strong Q4 2025 results with total revenues of $1.05 billion, up 5.3% year-over-year, driven by iTero Lumina upgrades and increased global demand across all business segments.

Feb 4

Data updated apr 24, 2026 5:14pm · Source: massive.com